Literature DB >> 6204101

Role of proteases in hypercatabolic patients with renal failure.

W H Hörl, J Stepinski, R M Schäfer, C Wanner, A Heidland.   

Abstract

Proteolytic enzymes exist in plasma ultrafiltrates, concentrated dialysates, and urine fractions of patients with posttraumatic acute renal failure (ARF), as well as in urine fractions of patients with nephrotic syndrome and in concentrated dialysates of patients or routine dialysis therapy (RDT). Differences in the digestion pattern of phosphorylase kinase suggest the existence on different proteases. Plasma trypsin-binding capacity is reduced in RDT patients and is markedly decreased in patients with posttraumatic ARF compared with healthy subjects. Protein catabolism of plasma fractions of patients with posttraumatic ARF is inhibited in vitro by alpha 2-macroglobulin. Urinary alpha 1-antitrypsin inactivates added kallikrein in urine fractions of patients with posttraumatic ARF or nephrotic syndrome. Proteases may also be involved in the disturbances of carbohydrate metabolism of uremic patients. The role of proteolytic degraded phosphorylase kinase, muscle contractile proteins, hormone receptors, or pancreas islets on the pathogenesis of altered carbohydrate metabolism in uremia is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6204101

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  2 in total

1.  Assessment of myeloperoxidase and oxidative alpha1-antitrypsin in patients on hemodialysis.

Authors:  Hirokazu Honda; Masashi Ueda; Shiho Kojima; Shinichi Mashiba; Yuki Hirai; Nozomu Hosaka; Hiroki Suzuki; Masanori Mukai; Makoto Watanabe; Keiko Takahashi; Kanji Shishido; Tadao Akizawa
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-07       Impact factor: 8.237

2.  Rhabdomyolysis recognized after elevation of liver enzymes following prolonged urologic surgery with lateral decubitus position -A case report-.

Authors:  Guie Yong Lee; Heeseung Lee; Youn Jin Kim
Journal:  Korean J Anesthesiol       Date:  2011-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.